Company & Sponsor Intelligence

National Taiwan University Hospital

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials7
Recruiting0
Completed3
Countries1

Therapeutic footprint

adhdautismstrokeunclassified

Indexed studies

NCT02820155Phase I Single and Multiple Escalating Dose Study of RGN1016 in Healthy Male Subjects
alzheimers · Taiwan
PHASE1
NCT00550667Clinical and Neuropsychological Validity of Attention-Deficit Hyperactivity Disorder in Adulthood
adhd · Taiwan
COMPLETED
NCT00756158Molecular Studies on the Candidate Genes of Dopaminergic and Noradrenergic Systems in ADHD
adhd · Taiwan
COMPLETED
NCT01724164Robot- Versus Mirror-Assisted Rehabilitation in Stroke Patients
stroke · Taiwan
NA
NCT01075373A Neurobiological Study on Heterogeneity of Schizophrenia: Genetic Variations and Neurobiological Differentiations
unclassified · Taiwan
UNKNOWN
NCT02533661Effects of Family-Centered Intervention for Preterm Infants at Preschool Age
unclassified · Taiwan
NA
NCT05884853The Plasticity of Social Brain Network in Adults With Autism Spectrum Disorder
autism · Taiwan
NA
NCT00713570Explore the Nature Factors Relevant to Learning-Pioneering Natural Factors That Influences Science Learning II
unclassified · Taiwan
UNKNOWN

Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →